UK and USA-based specialty drugmaker EUSA Pharma today announced the strengthening of its senior leadership… To continue reading The Pharma Letter please login, subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space.
Through an average career cycle, one can ebb and flow with the change of tides, finding themselves accidentally in various positions. With just enough sheer luck, one may even find advancement in a given field, acquiring just enough knowledge, insight, and experience required to perform all required
EUSA Pharma, the global specialized pharmaceutical giant focused on treatment and cure of rare diseases, along with oncology care, has recently announced the newest appointment to their impressive management. Carsten Thiel, the world renowned leader within the realm of biopharmaceutical marketing, has been carefully selected to serve as the company’s President Europe, making this a new venture for the pharmaceutical veteran.
Newly appointed President Europe of rapidly expanding global specialized pharmaceutical giant EUSA, which focuses on treatment and cure of rare diseases and oncology care, Carsten Thiel brings over twenty years of pertinent experience within the pharmaceutical sector to his new role.